FIELD: medical engineering.
SUBSTANCE: device has porous ceramic carrier layers and transverse bracing members, connected carcass having pores most of which have size from 20 to 1000 mcm and possessing density of 40% with respect to the theoretical one. Volume of the pores is optionally filled with a drug known to have controllable release rate from the filler.
EFFECT: enhanced effectiveness in providing controllable drug release rate from the filler.
30 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPLANTED PRODUCTS, CONTAINING NANOPARTICLES | 2009 |
|
RU2524644C2 |
| PEPTIDE CONJUGATED PARTICLES | 2013 |
|
RU2669346C2 |
| COMPOSITION WITH CONTROLLED-RELEASE COMPRISING GNRH-II | 1999 |
|
RU2233170C2 |
| PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
| APPLICATION OF A NEW TYROSINKINASE INHIBITOR, ANLOTINIBA, IN OSTEOSARCOMA AND CHONDROSARCOMA | 2019 |
|
RU2787235C2 |
| IL-8 INHIBITORS FOR USE IN TREATMENT OF SOME SARCOMAS | 2018 |
|
RU2787821C2 |
| SUSTAINED RELEASE SYSTEMS AND LOW DOSES OF ANDROGENS, METHODS OF THEIR PREPARING AND METHOD OF TREATMENT USING THESE SYSTEMS | 1992 |
|
RU2142276C1 |
| TISSUE REGENERATION MEMBRANE | 2010 |
|
RU2532345C2 |
| METHODS OF TREATMENT OF TUMOR METASTASIS | 2018 |
|
RU2799546C2 |
| TECHNOLOGY OF MAKING AN IMPLANT FOR BONE TISSUE REPLACEMENT | 2019 |
|
RU2708639C1 |
